Vitosa® (Next Generation Stevia — BGG)

Stevia rebaudiana
Evidence Level
Moderate
1 Clinical Trial
5 Documented Benefits
3/5 Evidence Score

Vitosa® is BGG's next-generation stevia ingredient — distinguished from generic stevia by quality optimization for taste profile and functional applications. Premium stevia for natural sweetener applications. Used for: natural sugar substitute, functional beverage sweetening, low-glycemic formulations.

Studied Dose Sweetener use per product specification (typically mg amounts)
Active Compound Steviol glycosides (stevioside, rebaudioside A and others)

Benefits

Natural Sugar Substitute

Vitosa provides natural intense sweetness without calories — relevant for diabetic, weight management, and clean-label formulations.

No Glycemic Impact

Steviol glycosides do not raise blood glucose — distinguishes from sugar; FDA generally recognized as safe (GRAS).

Improved Taste Profile (Next Generation)

Vitosa designed to address stevia's traditional bitter aftertaste — premium taste profile compared to early-generation stevia.

Heat-Stable for Cooking and Beverages

Stable in cooking and food/beverage processing — versatile applications.

Plant-Based / Natural Positioning

Plant-derived alternative to artificial sweeteners (sucralose, aspartame, saccharin).

Mechanism of action

1

Steviol Glycoside Sweetness

Stevia leaves contain steviol glycosides — naturally intensely sweet (200-400× sucrose); not metabolized for energy; excreted unchanged.

2

Bitter Receptor Considerations

Generic stevia activates bitter taste receptors causing aftertaste; next-generation stevia products like Vitosa minimize bitter compounds.

3

No Insulin Response

Does not stimulate insulin release; appropriate for diabetic dietary management.

Clinical trials

1
Stevia Glycemic Effects — Multiple Studies
PubMed

Multiple stevia studies on glycemic and metabolic markers.

Diabetic and healthy populations.

No glycemic impact; some studies suggest modest BP effects with chronic use.

Side effects and drug interactions

Common Potential side effects

Generally extremely well-tolerated.
Mild GI distress at very high doses (rare).
Some report bitter or licorice-like aftertaste (minimized in Vitosa next-generation).
Allergic reactions to Asteraceae rare.
FDA GRAS for steviol glycosides.

Important Drug interactions

Antihypertensives — modest BP effects; theoretical additive at high stevia doses.
Diabetes medications — modest hypoglycemic effects at very high doses (uncommon).
Lithium — theoretical (stevia may modestly affect renal function).
Pregnancy — generally considered safe at typical sweetening doses.
Lactation — generally safe.
Children — appropriate.

Frequently asked questions about Vitosa® (Next Generation Stevia — BGG)

What is Vitosa?

Vitosa® is BGG's next-generation stevia ingredient — distinguished from generic stevia by quality optimization for taste profile and functional applications. Premium stevia for natural sweetener applications. Used for: natural sugar substitute, functional beverage sweetening, low-glycemic formulations.

What is Vitosa used for?

Vitosa is researched primarily for Metabolic Health. Vitosa provides natural intense sweetness without calories — relevant for diabetic, weight management, and clean-label formulations.

What is the recommended dosage of Vitosa?

The clinically studied dose is Sweetener use per product specification (typically mg amounts) Always follow the product label and check with a healthcare provider for personal advice.

Is Vitosa safe, and does it have side effects?

For most healthy adults, Vitosa is well tolerated at studied doses. Reported effects can include: Generally extremely well-tolerated. Mild GI distress at very high doses (rare). It may also interact with some medications. Vitosa is not right for everyone, so check with a healthcare provider first if you are pregnant or breastfeeding, have a medical condition, or take prescription medication.

Does Vitosa interact with any medications?

Possible interactions include: Antihypertensives — modest BP effects; theoretical additive at high stevia doses. Diabetes medications — modest hypoglycemic effects at very high doses (uncommon). If you take prescription medication, check with a pharmacist or doctor before using it.

How strong is the scientific evidence for Vitosa?

NutraSmarts rates the evidence for Vitosa as Moderate (3 out of 5). It is backed by 1 clinical trial and 5 cited references summarized on this page. A higher rating reflects more, larger, and better-designed human studies.

References(5 citations)

Evidence ratings on NutraSmarts are based on the totality of human clinical research, with emphasis on randomized controlled trials, meta-analyses, and systematic reviews. The references below directly support claims made throughout this page.

  1. Anton SD, Martin CK, Han H, Coulon S, Cefalu WT, Geiselman P, Williamson DA Effects of stevia, aspartame, and sucrose on food intake, satiety, and postprandial glucose and insulin levels Appetite. 2010;55(1):37-43. doi: 10.1016/j.appet.2010.03.009.PubMedUsed to support: Human crossover trial showing stevia preloads did not raise postprandial glucose or insulin levels vs sucrose while providing equivalent satiety; backs 'no glycemic impact' and 'natural sugar substitute' benefits.
  2. Ajami M, Seyfi M, Hosseini FA, Naseri P, Velayati A, Mahmoudnia F, Zahedirad M, Hajifaraji M Effects of stevia on glycemic and lipid profile of type 2 diabetic patients: A randomized controlled trial Avicenna J Phytomed. 2020;10(2):118-127.PubMedUsed to support: RCT in type 2 diabetic patients showing stevia supplementation improved fasting blood glucose and lipid profile vs placebo; directly backs 'no glycemic impact' and 'natural sugar substitute' benefits.
  3. Hsieh MH, Chan P, Sue YM, Liu JC, Liang TH, Huang TY, Tomlinson B, Chow MS, Kao PF, Chen YJ Efficacy and tolerability of oral stevioside in patients with mild essential hypertension: a two-year, randomized, placebo-controlled study Clin Ther. 2003;25(11):2797-808. doi: 10.1016/s0149-2918(03)80334-x.PubMedUsed to support: 2-year RCT in hypertensive patients demonstrating stevioside was safe and well-tolerated; supports long-term safety/tolerability of stevia at the compound level.
  4. Farhat G, Berset V, Moore L Effects of Stevia Extract on Postprandial Glucose Response, Satiety and Energy Intake: A Three-Arm Crossover Trial Nutrients. 2019;11(12):3036. doi: 10.3390/nu11123036.PubMedUsed to support: 3-arm crossover RCT showing stevia extract did not raise postprandial glucose and was associated with reduced total energy intake vs sucrose; backs 'no glycemic impact' and 'natural sugar substitute' benefits.
  5. Zhang R, Noronha JC, Khan TA, McGlynn N, Back S, Grant SM, Kendall CW, Sievenpiper JL The Effect of Non-Nutritive Sweetened Beverages on Postprandial Glycemic and Endocrine Responses: A Systematic Review and Network Meta-Analysis Nutrients. 2023;15(4):1050. doi: 10.3390/nu15041050.PubMedUsed to support: Systematic review and network meta-analysis including stevia showing non-nutritive sweeteners (including stevia) do not raise postprandial blood glucose vs water or caloric sweeteners; backs 'no glycemic impact' and 'natural sugar substitute' benefits at the compound level.